
Investors should closely monitor news regarding a potential SpaceX IPO, as it represents a significant "liquidity dilution" risk for Tesla (TSLA). If a public offering is announced, consider reducing exposure to TSLA to protect against selling pressure as capital migrates toward the newer venture. This "Second Token" syndrome suggests that a founder’s original project often loses its valuation premium when a shinier, high-growth alternative becomes available. For those seeking exposure to Elon Musk’s innovation narrative, preparing for a shift from TSLA to SpaceX may be the most strategic long-term move. Be wary of any high-profile founder launching a competing project, as community fragmentation typically leads to a decline in the original asset's momentum.